Formulation andin vitroevaluation of ciprofloxacin containing niosomes for pulmonary delivery

Adi H, 2008, J Pharm Sci, 97, 3356, 10.1002/jps.21239

Arppe J, 1998, Int J Pharm, 161, 205, 10.1016/S0378-5173(97)00351-7

10.1021/js980286u

Bosso JA, 1989, Am J Med, 87, S123, 10.1016/0002-9343(89)90040-5

Bozeman L, 2005, Clin Infect Dis, 40, 386, 10.1086/427292

Brown AE, 1989, Am J Med, 87, S266, 10.1016/0002-9343(89)90077-6

Bush A, 2002, Paediatr Respir Rev, 3, 82

Cavallo J, 2002, Antimicrob Agents Chemother, 46, 2307, 10.1128/AAC.46.7.2307-2309.2002

Cheung DOY, 2000, Infect Immun, 68, 4585, 10.1128/IAI.68.8.4585-4592.2000

Chougule MB, 2006, J Nanosci Nanothechnol, 9, 1

Conley J, 1997, Antimicrob Agents Chemother, 41, 1288, 10.1128/AAC.41.6.1288

Conway S, 2003, Am J Respir Med, 2, 321, 10.1007/BF03256660

10.1016/S0378-5173(02)00245-4

Easmon CCF, 1985, J Antimicrob Chemother, 16, 67, 10.1093/jac/16.1.67

10.1016/S0378-5173(01)00627-5

Fenske DB, 2007, Liposome Technology: Entrapment of Drugs and Other Materials into Liposomes, 2, 27

Finlay WH, 1998, Int J Pharm, 167, 121, 10.1016/S0378-5173(98)00055-6

10.1378/chest.123.1.28

10.1016/j.ijpharm.2008.01.046

10.1089/jam.2006.19.54

Huang YY, 2006, J Control Release, 113, 9, 10.1016/j.jconrel.2006.03.014

Hwang SH, 1999, Int J Pharm, 179, 85, 10.1016/S0378-5173(98)00392-5

Joshi M, 2001, Int J Pharm, 223, 15, 10.1016/S0378-5173(01)00705-0

Joshi M, 2001, AAPS Pharm Sci Technol, 4, 1

Kleemann E, 2007, Pharm Res, 24, 277, 10.1007/PL00022055

Lai H, 2004, Am J Epidemiol, 159, 537, 10.1093/aje/kwh083

Lawrence MJ, 1996, STP Pharm Sci, 6, 49

Li Z, 2008, J Aerosol Med Pulm Drug Deliv, 21, 245, 10.1089/jamp.2008.0686

10.1007/s00396-006-1627-z

LoBue PA, 2005, Chest, 127, 1098

Meers P, 2008, J Antimicrob Chemother, 61, 859, 10.1093/jac/dkn059

10.1093/jac/dkh518

10.1128/AAC.01547-05

Newman SP, 2005, Respir Care, 50, 177

Niven RW, 1997, Inhalation Delivery of Therapeutic Peptides and Proteins, 412

Oh YK, 1995, Antimicrob Agents Chemother, 39, 2104, 10.1128/AAC.39.9.2104

Omri A, 2002, Int J Antimicrob Agents, 64, 1407

10.1016/j.ijpharm.2006.08.002

10.3109/10611869409015907

Seras-Cansel A, 1996, STP Pharm Sci, 6, 12

Steward J, 2006, Int J Antimicrob Agents, 27, 439, 10.1016/j.ijantimicag.2006.02.006

10.1016/j.ijpharm.2005.09.010

Tomlin K, 2004, J Microbiol Methods, 57, 95, 10.1016/j.mimet.2003.12.007

Uchegbu IF, 1998, Int J Pharm, 172, 33, 10.1016/S0378-5173(98)00169-0

10.1080/drd_10_4_251

Vervaet C, 1999, Int J Pharm, 186, 13, 10.1016/S0378-5173(99)00134-9

Vyas SP, 2004, Int J Pharm, 269, 37, 10.1016/j.ijpharm.2003.08.017

Wong JP, 2003, J Control Release, 92, 256

Yoshioka T, 1994, Int J Pharm, 105, 1, 10.1016/0378-5173(94)90228-3